Variable | Patients with SLE, n = 95 | Control Subjects, n = 100 | p |
---|---|---|---|
Demographics | |||
Age, yrs | 34.7 (10.1) | 34.8 (9.7) | 0.97 |
Education, yrs | 13.3 (3.6) | 13.9 (2.9) | 0.31 |
Body mass index, kg/m2 | 26.6 (5.8) | 27.9 (4.2) | 0.006 |
Waist circumference, cm | 90.3 (14.5) | 94.3 (11.2) | 0.007 |
Coronary artery risk factors, n (%) | |||
Current smoking | 18 (19) | 23 (23) | 0.59 |
Ever smoking | 48 (51) | 49 (49) | 0.89 |
Hypertension† | 37 (39) | 4 (4) | < 0.001 |
Systolic blood pressure, mm/Hg | 115.8 (9.5) | 113.4 (10.4) | 0.03 |
Diastolic blood pressure, mm/Hg | 74.5 (8.5) | 76.7 (6.9) | 0.03 |
Diabetes | 8 (8) | 4 (4) | 0.24 |
Total cholesterol, mg/dl | 184.2 (57.4) | 199.1 (36.2) | < 0.001 |
Low-density lipoprotein, mg/dl | 112.4 (41.9) | 121.5 (29.4) | 0.007 |
High-density lipoprotein, mg/dl | 39.1 (11.4) | 48.9 (8.9) | 0.001 |
Triglycerides, mg/dl | 172.7 (117.7) | 183.1 (110.8) | 0.54 |
Glucose, mg/dl | 89.7 (15.6) | 105.9 (44.8) | < 0.001 |
Apolipoprotein B, mg/dl | 96.9 (30.6) | 105.6 (22.3) | < 0.001 |
Creatinine, mg/dl | 0.93 (0.36–19.04) | 0.95 (0.65–1.36) | 0.66 |
eGFR (CKD-EPI), ml/min | 105.0 (3.0–169) | 103.5 (60–131) | 0.83 |
eGFR < 60 ml/min, n (%) | 15 (16) | 0 | < 0.001 |
Homocysteine, mg/dl | 14.3 (10.1) | 9.6 (3.0) | < 0.001 |
Ultrasensitive CRP, mg/l | 4.96 (11.7) | 2.4 (3.6) | 0.06 |
MetS, n (%) | 34 (36) | 34 (34) | 0.88 |
Framingham risk score | 3 (2–25) | 3 (2–18) | 0.32 |
Coronary artery calcification, n (%)‡ | 17 (18) | 7 (7) | 0.03 |
↵† Hypertension defined as systolic bood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg.
↵‡ Coronary artery calcification defined as total calcium score > 0. SLE: systemic lupus erythematosus; MetS: metabolic syndrome; eGFR: estimated glomerular filtration rate; CRP: C-reactive protein; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration.